Clinical trial / 2007
Systemic lycopene supplementation improved clinical measures of gingivitis over two weeks.
In a randomised, double-blind, split-mouth trial, 20 systemically healthy patients with gingivitis were assigned to 8 mg lycopene/day (n = 10) or placebo (n = 10) for 2 weeks, with two quadrants receiving oral prophylaxis (OP) and two quadrants untreated (non-OP). OP-lycopene led to a statistically significant decrease in GI compared with OP-placebo (p < 0.05) and non-OP-placebo (p < 0.01), while non-OP-lycopene reduced GI compared with non-OP-placebo (p < 0.01). OP-lycopene also reduced SBI compared with non-OP-lycopene (p < 0.05) and non-OP-placebo (p < 0.001). A strong negative correlation was found between salivary uric acid levels and percentage reduction in GI at 1 and 2 weeks in the OP-lycopene group (r = -0.852 and -0.802) and non-OP-lycopene group (r = -0.640 and -0.580).
- Study type
- Randomised, double-blind, parallel, split-mouth trial
- Who was studied
- 20 systemically healthy patients with clinical signs of gingivitis
- What was measured
- Bleeding index (SBI), plaque index (PI), gingival index (GI), and salivary uric acid levels
THE PAPER
Efficacy of lycopene in the treatment of gingivitis: a randomised, placebo-controlled clinical trial.
Chandra RV, Prabhuji ML, Roopa DA, Ravirajan S, Kishore HC. Oral Health Prev Dent, 2007.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.